Loading Events
  • This event has passed.

Microbiome and Biotechs: What Promises and How to Get to Market

Neighborhood invites you to join our panel around the topic of Microbiome to better understand the Microbiome. Our goal is to bring experienced and knowledgeable people on stage to share their thoughts with the audience.

  • The link between the first scientific discoveries (INRA, Metagenopolis) and the birth of the first biotechs in France in the microbiome.
  • The most obvious… and most hypothetical potential applications ;
  • The state of knowledge around the  microbiome (can everything be understood and cured thanks to the  microbiome?) ;
  • Regulatory/technical obstacles to the use of living biotherapies in clinics;
  • The interest of financial investors and the pharmaceutical industry in the microbiome, etc.

Speakers:

Pierre Belichard
CEO at Enterome
Pierre Belichard has served as Chief Executive Officer since 2011 and as a member of the board of directors since 2011. Previously, Dr. Belichard served as Vice President of Mergers and Acquisitions and Business Development at Sanofi Ophthalmology from 2009 to 2011. Dr. Belichard was the Founder of Fovea Pharmaceuticals SA. and served as the Chief Operating Officer from 2005 to 2009. From 2002 to 2004, Dr. Belichard served as Vice President of Business Development at UroGene, S.A., a company acquired by Pierre Fabre in 2004. From 2000 to 2002, he served as head of European commercial operations at Ethypharm S.A. Dr. Belichard holds a Pharm.D. from Grenoble Faculty of Medicine and Pharmacy, Ph.D. from University Pierre and Marie Curie and an M.B.A. from INSEAD.

 

Isabelle de Crémoux
CEO of Seventure
Isabelle is CEO and Managing Partner and leads the Life Sciences team. Isabelle has a particular interest in the microbiome field and frequently gives lectures at conferences in this domain. She was the founder of Health for Life Capital fund, which primary focus is microbiome, in partnership with Danone and Novartis. Isabelle has a degree in Engineering from l’Ecole Centrale Paris and holds DECF and ISEB degrees and brings more than 25 years of international business development and finance experience in the pharmaceutical industry to the team.

 

Georges Rawadi 
CEO of LNC
Former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad. He previously served in various business development roles at Cellectis, Galapagos, ProStrakan and Sanofi-Aventis and led strategic alliance development consulting assignments. He holds a PhD in Microbiology from Pierre and Marie Curie University (France) and a master’s degree in Management and Strategy in the Health Industry from ESSEC Business School.

 

Pierre Rimbaud
Clinical Development Expert
Doctor of Medecine, Dr Pierre Rimbaud is a renowned expert in the clinical development of therapies targeting the microbiome. He is co-founder of several biotech companies involved in the field of microbiome (MaaT Pharma, Enterome, etc.). He currently serves as strategic adviser for many companies.